These data reconcile with studies by Lui et al. that unveiled TAM-secreted CCL20 as another mediator for iNKT cell recruitment to the tumor microenvironment under hypoxic conditions [102] after CCL20 had been pointed out as a selective chemoattractant for DCs, effector-memory T cells [103] and NKT cells [104]. The gene discussed is CCL20; the disease is neoplasm.